HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph A Hrabie Selected Research

proline-nitric oxide

9/2010Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes.
12/2008Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.
1/2008Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia.
1/2008Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph A Hrabie Research Topics

Disease

5Hyperplasia
03/2013 - 01/2008
2Carotid Artery Injuries
12/2008 - 01/2008
2Inflammation (Inflammations)
01/2008 - 01/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2010
1Diabetes Mellitus
12/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2008
1Suppuration
03/2006

Drug/Important Bio-Agent (IBA)

6Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2013 - 03/2006
4proline-nitric oxideIBA
09/2010 - 01/2008
1Insulin (Novolin)FDA Link
09/2010
1Streptozocin (Streptozotocin)FDA Link
09/2010
1dihydroethidiumIBA
12/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008
1GelsIBA
01/2008
1PowdersIBA
01/2008
1diazeniumdiolated poly(acrylonitrile)IBA
01/2008
1diazeniumdiolateIBA
01/2008
1Poloxamer (Poloxamer 407)IBA
01/2008
1Polyurethanes (Polyurethane)IBA
03/2006

Therapy/Procedure

3Therapeutics
12/2008 - 01/2008
1Catheters
03/2013